OPUS GENETICS
Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.
OPUS GENETICS
Industry:
Health Care Health Diagnostics Wellness
Founded:
2004-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.opusgtx.com
Status:
Active
Contact:
919-525-9820
Total Funding:
19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
AppliedVR
AppliedVR offers virtual reality-based therapeutic treatments that address the complexity of chronic pain.
Careship
Careship helps families find the right caregiver for their loved ones.
CorSanitas
CorSanitas is a healthcare company that assists its members as they reverse their heart disease and any accompanying conditions.
DaoCloud
DaoCloud is the largest national network of vetted wellness practitioners.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
GOJO Industries
GOJO Industries is a company that offers health skin and hygiene solutions.
Gravity Diagnostics
Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing.
HealthPoint Plus
HealthPoint Plus is disrupting the way patients access primary care with subscription-based medicine.
Immunostics
Immunostics offers a broad portfolio of diagnostics solutions.
InFuse Holdings
InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers.
Kikoko
Kikoko is a cannabis botanical wellness company for women.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Lyme Diagnostics Ltd.
Lyme Diagnostics offers reliable, standard diagnostic system for diagnosing Lyme borreliosis.
MeetMindful
MeetMindful is a dating site platform for people who are into health, well-being, and mindfulness.
Monument
Monument is an alcohol addiction treatment platform for those looking to change their relationship with alcohol.
Native American Connections (NAC)
Native American Connections (NAC) is an innovative multi-service organization working to improve community health and wellness
NICE Recovery Systems
NICE Recovery Systems is a provider of therapy device to improve the convenience and efficacy of cold plus compression therapy.
Oppimi
Oppimi creates therapeutic tools for diagnosing and treating learning disabilities using a video-game approach.
OPUS
At-home wellness tech for emotional fitness
Quit Genius
Quit Genius is a digital clinic for treating nicotine, alcohol, and opioid addictions.
Seven Starling
Seven Starling is a digital clinic uniquely focused on treating perinatal mental health conditions.
Squatty Potty
An American personal care company
Sunniva
Sunniva is a vertically integrated medical company.
Two Chairs
Two Chairs is a behavioral health company that operates a mental health therapy platform to offer in-person psychotherapy.
Upside Health
At Upside Health, we’re transforming the way chronic pain is assessed and treated.
Vision Healthcare
Vision Healthcare is a consumer healthcare company active in different European countries.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Wallflowr
Wallflowr mission is to empower Networks to become resources for professional wellness for their growing communities.
Current Advisors List
Board_member
2021-01-01
Board_member
Current Employees Featured
Joe Schachle Chief Operating Officer @ Opus Genetics
Chief Operating Officer
Jennifer Hunt CDO @ Opus Genetics
CDO
2022-05-01
Ash Jayagopal Chief Scientific Officer @ Opus Genetics
Chief Scientific Officer
Jason D. Menzo Co-Founder @ Opus Genetics
Co-Founder
2021-01-01
Peter Ginsberg Co-Founder @ Opus Genetics
Co-Founder
Benjamin Yerxa CEO @ Opus Genetics
CEO
2022-06-01
Rusty Kelley Co-Founder & Board Director @ Opus Genetics
Co-Founder & Board Director
2021-01-01
Jean Bennett Co-Founder @ Opus Genetics
Co-Founder
Founder
Investors List
Bios Partners
Bios Partners investment in Seed Round - Opus Genetics
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Seed Round - Opus Genetics
Manning Family Foundation
Manning Family Foundation investment in Seed Round - Opus Genetics
Key Employee Changes
Official Site Inspections
http://www.opusgtx.com Semrush global rank: 5.62 M Semrush visits lastest month: 1.51 K
- Host name: 172.67.177.251
- IP address: 172.67.177.251
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Opus Genetics"
Company Information :: Opus Genetics, Inc. (IRD) - ir.opusgtx.com
The company is a clinical-stage ophthalmic biotechnology company developing therapies to treat patients with inherited retinal diseases (IRDs) and other ophthalmic disorders. The pipeline …See details»
Opus Genetics - Home
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment of inherited retinal diseases (IRDs) and other retinal and refractive disorders.See details»
Company Overview - Opus Genetics
Advancing first-in-class retinal gene therapies Opus Genetics is committed to building an innovative, efficient and sustainable clinical-stage ophthalmic biopharmaceutical company leading the development of transformative gene …See details»
Ocuphire Pharma Announces Acquisition of Opus …
Oct 22, 2024 Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate safety …See details»
Opus Genetics Files Definitive Proxy Statement and …
4 days ago Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the Company’s …See details»
Opus Genetics - LinkedIn
Opus Genetics | 3,401 followers on LinkedIn. Gene therapy company for inherited retinal diseases | Ocuphire Pharma, Inc. and Opus Genetics have combined under the Opus Genetics name (Nasdaq: IRD ...See details»
George Magrath, MD, MBA, MS - Opus Genetics - opusgtx.com
Dr. Magrath, MD, currently serves as Chief Executive Officer and a Board member of Opus Genetics, which was recently acquired by Ocuphire Pharma during his tenure there as CEO. …See details»
Opus Genetics - lifesciencehistory.com
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other …See details»
Opus Genetics - VentureRadar
"Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Our AAV-based gene therapy portfolio, based on the work of …See details»
Opus Genetics - Company Profile - Tracxn
Feb 2, 2025 Opus Genetics - Developer of gene therapies to treat retinal degenerative diseases. Acquired by Ocuphire. Raised a total funding of $23.5M over 2 rounds from 3 investors.See details»
Opus Genetics (acquired in 2024)) 2025 Company Profile: …
May 18, 2021 Information on acquisition, funding, cap tables, investors, and executives for Opus Genetics (acquired in 2024)). Use the PitchBook Platform to explore the full profile.See details»
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
Feb 18, 2025 We have reached agreement with the FDA on a SPA for a Phase 3 trial to evaluate oral APX3330 for the treatment of DR. For more information, please visit …See details»
Opus Genetics - Overview, News & Similar companies
View Opus Genetics (opusgtx.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Opus Genetics’s Competitors, Revenue, Number of Employees
Opus Genetics is headquartered in Durham, North Carolina. Opus Genetics has been a Acquired of Ocuphire Pharma, Inc. since Oct 2024. Opus Genetics has raised a total of $34.7M in …See details»
Our Approach - Opus Genetics
Opus’ unique approach Validated science, well characterized material by preeminent leaders in the field, and safe and effective retinal transduction by AAV Insight & experience of our …See details»
Opus Genetics Announces Financial Results for Full Year 2024
Mar 31, 2025 We have reached agreement with the FDA under SPA for a Phase 3 trial to evaluate oral APX3330 for the treatment of DR more information, please visit www.opusgtx.com.See details»
Opus Genetics Leadership to Present at 3rd Annual Gene Therapy …
Sep 12, 2022 RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-first gene therapy company developing treatments for inherited …See details»
Opus Genetics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Jun 15, 2023 For more information, please visit www.opusgtx.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private …See details»
Patients & Families - Opus Genetics - opusgtx.com
Built by and for patients, Opus’ first three programs are being developed to address retinal diseases caused by mutations in the LCA5, RDH12 and NMNAT1 genes.See details»
Opus Genetics Leadership to Present at 3rd Annual Gene
Sep 12, 2022 Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s …See details»